Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Mycoses 2Invasive Fungal Infections 2Pulmonary Aspergillosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia 1Invasive Pulmonary Aspergillosis 1Hematologic Neoplasms 1HIV Infections 1Carcinoma, Hepatocellular 1Aspergillosis 1

Interventions

pegfilgrastim 26Filgrastim 24Cyclophosphamide 8Docetaxel 7Etoposide 6pegylated granulocyte colony-stimulating factor 5Cytarabine 5eflapegrastim 4Granulocyte Colony-Stimulating Factor 4Leucovorin 3Fluorouracil 3Doxorubicin 3Cyclosporine 3Cefepime 3Caspofungin 3Carboplatin 3liposomal amphotericin B 2Vincristine 2Vancomycin 2Topotecan 2Methylprednisolone 2Methotrexate 2Itraconazole 2Irinotecan 2Ifosfamide 2Idarubicin 2Fluconazole 2Daunorubicin 2Cisplatin 2Amikacin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neutropenia × Amphotericin B × Clear all
NCT00002277 2005-06-24

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NIH AIDS Clinical Trials Information Service

Phase 3 Completed

Mycoses, Neoplasms, Neutropenia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡